Lewis Sanders
Sanders Capital
Sanders Capital 13F holdings
Lewis Sanders's Portfolio
- Portfolio value:
- $36.36B≈
- # of securities:
- 42
- Reported for:
- 30 Sep 2022 (Q3)
- Latest filing date:
- 17 Feb 2023
What stocks did Lewis Sanders own in 2022 Q3?
What was Lewis Sanders's 2022 Q3 portfolio?
Sanders Capital has disclosed a total of 42 security holdings in their (2022 Q3) SEC 13F filing(s) with portfolio value of $36,358,401,000.
Sanders Capital's portfolio holdings are tracked quarterly based on SEC 13F filings. Snapshots for each reporting period document the full list of disclosed positions and their portfolio allocations.
Lewis Sanders's original 13F reports (2022 Q3) are the official SEC institutional disclosure documents covering all reported equity positions.
42 results
| History | Ticker | Name |
% of portfolio |
Shares* |
Reported price* |
% difference current price* |
Value | Held since* | Held for* |
Security type |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
UnitedHealth Group Incorporated
|
9.59%
|
6,903,574
|
$505.04
|
-16.96%($419.36)
|
$3,486,581,000
|
2013 Q2 or earlier
|
≈ 9.50+ years
|
Common Stock
|
+0.15% (+10.41K)
|
+0.01%
|
|
|
|
Alphabet Inc, CL-C
|
8.75%
|
33,084,588
|
$96.15
|
+268.07%($353.90)
|
$3,181,083,000
|
2016 Q3
|
≈ 6.25 years
|
Common Stock
|
+1.36% (+443.81K)
|
+0.12%
|
|
|
|
Taiwan Semiconductor Manufacturing
|
8.10%
|
42,934,330
|
$68.56
|
+493.90%($407.18)
|
$2,943,578,000
|
2014 Q3
|
≈ 8.25 years
|
Depositary Receipt
|
+3.48% (+1.45M)
|
+0.27%
|
|
|
|
Microsoft Corp
|
6.41%
|
10,001,400
|
$232.90
|
+98.01%($461.18)
|
$2,329,326,000
|
2013 Q2 or earlier
|
≈ 9.50+ years
|
Common Stock
|
+1.60% (+157.39K)
|
+0.1%
|
|
|
|
Apple Inc
|
6.29%
|
16,557,604
|
$138.20
|
+117.97%($301.23)
|
$2,288,261,000
|
2013 Q3
|
≈ 9.25 years
|
Common Stock
|
+1.47% (+239.62K)
|
+0.09%
|
|
|
|
Micron Technology Inc
|
5.81%
|
42,131,053
|
$50.10
|
+1,600.62%($852.01)
|
$2,110,766,000
|
2018 Q4
|
≈ 4.00 years
|
Common Stock
|
+0.45% (+190.55K)
|
+0.03%
|
|
|
|
HCA Healthcare, Inc
|
5.62%
|
11,124,743
|
$183.79
|
+118.13%($400.90)
|
$2,044,617,000
|
2020 Q2
|
≈ 2.50 years
|
Common Stock
|
+0.04% (+4.25K)
|
+0%
|
|
|
|
Cigna Corp
|
5.62%
|
7,364,971
|
$277.47
|
|
$2,043,559,000
|
2013 Q2 or earlier
|
≈ 9.50+ years
|
Common Stock
|
-1.22% (-91.12K)
|
-0.06%
|
|
|
|
Elevance Health Inc
|
4.95%
|
3,964,817
|
$454.24
|
-16.86%($377.65)
|
$1,800,978,000
|
2014 Q4
|
≈ 8.00 years
|
Common Stock
|
-2.78% (-113.27K)
|
-0.13%
|
|
|
|
Meta Platforms Inc
|
4.16%
|
11,136,309
|
$135.68
|
+304.77%($549.19)
|
$1,510,974,000
|
2018 Q3
|
≈ 4.25 years
|
Common Stock
|
+1.86% (+203.1K)
|
+0.08%
|
|
Completely sold out
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.